These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25325114)

  • 1. Development of meningococcal B vaccines.
    Prescrire Int; 2014 Sep; 23(152):204. PubMed ID: 25325114
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal B vaccine. An immunogenic vaccine possibly useful during outbreaks.
    Prescrire Int; 2014 Sep; 23(152):201-4. PubMed ID: 25325113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of group B meningococcal disease by vaccination: a difficult task.
    Thomas M
    N Z Med J; 2004 Aug; 117(1200):U1016. PubMed ID: 15475986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningococcus infection: problem actuality].
    Tereshchuk TO; Chugriiev AM
    Lik Sprava; 2011; (3-4):41-4. PubMed ID: 22416362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A routine infant schedule versus an older infant/toddler schedule for Neisseria meningitidis vaccination: what do experience and reason tell us?
    Black S; Shinefield H
    Expert Rev Vaccines; 2009 Dec; 8(12):1623-6. PubMed ID: 19943757
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination strategies for the prevention of meningococcal disease.
    Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination.
    Parikh SR; Campbell H; Beebeejaun K; Ribeiro S; Gray SJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2016 Aug; 22(8):1505-7. PubMed ID: 27433852
    [No Abstract]   [Full Text] [Related]  

  • 10. A multivalent conjugate vaccine for prevention of meningococcal disease in infants.
    Harrison LH
    JAMA; 2008 Jan; 299(2):217-9. PubMed ID: 18182606
    [No Abstract]   [Full Text] [Related]  

  • 11. From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.
    Caron F; du Châtelet IP; Leroy JP; Ruckly C; Blanchard M; Bohic N; Massy N; Morer I; Floret D; Delbos V; Hong E; Révillion M; Berthelot G; Lemée L; Deghmane AE; Bénichou J; Lévy-Bruhl D; Taha MK
    Lancet Infect Dis; 2011 Jun; 11(6):455-63. PubMed ID: 21489881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
    Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
    Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.
    Li Y; Sun YH; Ison C; Levine MM; Tang CM
    Infect Immun; 2004 Jan; 72(1):345-51. PubMed ID: 14688114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.
    Hoiseth SK; Murphy E; Andrew L; Vogel U; Frosch M; Hellenbrand W; Abad R; Vazquez JA; Borrow R; Findlow J; Taha MK; Deghmane AE; Caugant DA; Kriz P; Musilek M; Mayer LW; Wang X; Macneil JR; York L; Tan CY; Jansen KU; Anderson AS
    Pediatr Infect Dis J; 2013 Oct; 32(10):1096-101. PubMed ID: 23694830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac.
    Caron F; Delbos V; Houivet E; Deghmane AE; Leroy JP; Hong E; Bénichou J; Taha MK
    Vaccine; 2012 Jul; 30(34):5059-62. PubMed ID: 22658929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meningococcal disease and vaccines: still many questions and some answers].
    Godoy P; Castilla J; Astray J; Tuells J; Barrabeig I; Domínguez À
    Gac Sanit; 2020; 34(1):1-3. PubMed ID: 31767200
    [No Abstract]   [Full Text] [Related]  

  • 18. Fighting Neisseria meningitidis: past and current vaccination strategies.
    Piccini G; Torelli A; Gianchecchi E; Piccirella S; Montomoli E
    Expert Rev Vaccines; 2016 Nov; 15(11):1393-1407. PubMed ID: 27158988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup B meningococcal disease: new outbreaks, new strategies.
    Wenger JD
    JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
    [No Abstract]   [Full Text] [Related]  

  • 20. Indirect effects by meningococcal vaccines: herd protection versus herd immunity.
    Bröker M
    Hum Vaccin; 2011 Aug; 7(8):881-2. PubMed ID: 21785283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.